Andromeda Surgical Raises $15M to Scale Autonomous Surgery

The big picture: San Francisco-based medtech startup Andromeda Surgical has raised $15 million in a Series A round led by Standard Capital. The company, founded in 2023 by Nick Damiano and Kartik Tiwari, is developing an autonomous surgical platform designed to expand access to specialized procedures and reduce the training time required for surgeons. Andromeda Surgical initially focuses on HoLEP, a specialized urological procedure.

Why it matters:

• Access to care: Andromeda Surgical’s platform aims to enable hospitals to perform specialized procedures without relying on a narrowly focused expert being available on site, addressing a critical shortage of specialized surgeons.
• Efficiency and training: By automating aspects of surgery, the platform can potentially reduce the extensive training time required for surgeons and standardize complex procedures.
• Market potential: The investment underscores growing confidence in AI-driven solutions for healthcare, particularly in high-stakes areas like surgery, promising significant market disruption and improved patient outcomes.

How it works:

• Autonomous platform: Andromeda Surgical is building an autonomous surgical system designed to assist or perform specialized procedures, starting with HoLEP.
• Commercialization: The fresh capital will be used to advance regulatory processes, manufacture and deploy commercial units, and further develop its autonomous surgical capabilities.
• Expansion: The company plans to expand the use of its platform beyond its initial focus on HoLEP, supporting its transition into the commercial phase and broader deployment across hospitals.

The catch: The autonomous surgical market faces significant regulatory hurdles and requires extensive validation to ensure patient safety. Competition from established medical device companies and other surgical robotics startups is intense, and hospital adoption may be slow due to high capital costs and the need for new training protocols.